Aerie Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye today announced that Richard Rubino, Chief Financial Officer, will present at the H.C. Wainwright Global Investment Conference on Tuesday, September 10, 2019 at 9:35 a.m. Eastern Time in New York,